1. Home
  2. CRIS vs EBON Comparison

CRIS vs EBON Comparison

Compare CRIS & EBON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
    SELLHOLDBUYas of an hour ago
  • EBON
    SELLHOLDBUYas of an hour ago
  • Stock Information
  • Founded
  • CRIS 2000
  • EBON 2010
  • Country
  • CRIS United States
  • EBON China
  • Employees
  • CRIS N/A
  • EBON N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • EBON Semiconductors
  • Sector
  • CRIS Health Care
  • EBON Technology
  • Exchange
  • CRIS Nasdaq
  • EBON Nasdaq
  • Market Cap
  • CRIS 32.8M
  • EBON 27.6M
  • IPO Year
  • CRIS 2000
  • EBON 2020
  • Fundamental
  • Price
  • CRIS $1.38
  • EBON $3.75
  • Analyst Decision
  • CRIS Strong Buy
  • EBON
  • Analyst Count
  • CRIS 3
  • EBON 0
  • Target Price
  • CRIS $21.00
  • EBON N/A
  • AVG Volume (30 Days)
  • CRIS 54.9K
  • EBON 4.9K
  • Earning Date
  • CRIS 03-31-2025
  • EBON 04-25-2025
  • Dividend Yield
  • CRIS N/A
  • EBON N/A
  • EPS Growth
  • CRIS N/A
  • EBON N/A
  • EPS
  • CRIS N/A
  • EBON N/A
  • Revenue
  • CRIS $10,908,000.00
  • EBON $3,591,648.00
  • Revenue This Year
  • CRIS N/A
  • EBON N/A
  • Revenue Next Year
  • CRIS $27.88
  • EBON N/A
  • P/E Ratio
  • CRIS N/A
  • EBON N/A
  • Revenue Growth
  • CRIS 8.83
  • EBON N/A
  • 52 Week Low
  • CRIS $1.40
  • EBON $3.80
  • 52 Week High
  • CRIS $17.49
  • EBON $10.94
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 15.17
  • EBON 30.49
  • Support Level
  • CRIS $1.40
  • EBON $3.80
  • Resistance Level
  • CRIS $2.62
  • EBON $4.10
  • Average True Range (ATR)
  • CRIS 0.26
  • EBON 0.21
  • MACD
  • CRIS -0.12
  • EBON -0.01
  • Stochastic Oscillator
  • CRIS 3.84
  • EBON 0.00

Stock Price Comparison Chart: CRIS vs EBON

CRIS
EBON
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120130140CRIS VS EBON

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use